Drp1 mitochondrial fission in astrocyte modulates behavior and neuroinflammation during morphine addiction

Xiaotong Gu1, Wenjing Chen1, Zixin Li1

  • 1State Key Laboratory of Digital Medical Engineering, School of Biomedical Engineering, Hainan University, Sanya, 572025, China.

PubMed
Abstract

Insights

Morphine addiction involves mitochondrial fragmentation and neuroinflammation, particularly in astrocytes. Inhibiting mitochondrial fission protein Drp1 in astrocytes alleviates addiction behaviors and reduces inflammation, offering new therapeutic targets for substance use disorder.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Mitochondrial dynamics and neuroinflammation are key in morphine exposure.
  • The precise link between mitochondrial dynamics and neuroinflammation in morphine addiction remains unclear.

Purpose of the Study:

  • To investigate the role of astrocyte dynamin-related protein 1 (Drp1) in neuroinflammation during morphine addiction.
  • To explore the therapeutic potential of targeting mitochondrial dynamics in substance use disorder (SUD).

Main Methods:

  • Analysis of nucleus accumbens (NAc) tissues using immunofluorescence, transmission electron microscopy (TEM), and qRT-PCR.
  • Assessment of morphine-induced behaviors using conditioned place preference (CPP) and open field tests (OFT).
  • Pharmacological inhibition of Drp1 using Mdivi-1 and genetic knockdown of astrocyte Drp1 via adeno-associated virus (AAV) vectors.

Main Results:

  • Repeated morphine exposure caused mitochondrial fragmentation and increased inflammatory markers in NAc neurons, astrocytes, and microglia.
  • Mdivi-1 treatment reduced mitochondrial fragmentation, astrocyte-mediated neuroinflammation, and morphine-induced addictive behaviors.
  • Astrocyte-specific knockdown of Drp1 significantly decreased drug-seeking behavior and neuroinflammation.

Conclusions:

  • Astrocyte mitochondrial dynamics, regulated by Drp1, are crucial in morphine addiction-related neuroinflammation.
  • Targeting astrocyte mitochondrial dynamics presents a promising therapeutic strategy for SUD.